Thiopurine pharmacogenomics: Association of SNPs with clinical response and functional validation of candidate genes

Alice Matimba, Fang Li, Alina Livshits, Cher S. Cartwright, Stephen Scully, Brooke L. Fridley, Gregory Jenkins, Anthony Batzler, Liewei M Wang, Richard M Weinshilboum, Lynne Lennard

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Aim: We investigated candidate genes associated with thiopurine metabolism and clinical response in childhood acute lymphoblastic leukemia. Materials & methods: We performed genome-wide SNP association studies of 6-thioguanine and 6-mercaptopurine cytotoxicity using lymphoblastoid cell lines. We then genotyped the top SNPs associated with lymphoblastoid cell line cytotoxicity, together with tagSNPs for genes in the 'thiopurine pathway' (686 total SNPs), in DNA from 589 Caucasian UK ALL97 patients. Functional validation studies were performed by siRNA knockdown in cancer cell lines. Results: SNPs in the thiopurine pathway genes ABCC4, ABCC5, IMPDH1, ITPA, SLC28A3 and XDH, and SNPs located within or near ATP6AP2, FRMD4B, GNG2, KCNMA1 and NME1, were associated with clinical response and measures of thiopurine metabolism. Functional validation showed shifts in cytotoxicity for these genes. Conclusion: The clinical response to thiopurines may be regulated by variation in known thiopurine pathway genes and additional novel genes outside of the thiopurine pathway.

Original languageEnglish (US)
Pages (from-to)433-447
Number of pages15
JournalPharmacogenomics
Volume15
Issue number4
DOIs
StatePublished - 2014

Fingerprint

Pharmacogenetics
Single Nucleotide Polymorphism
Genes
Cell Line
Thioguanine
6-Mercaptopurine
Validation Studies
Genome-Wide Association Study
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Small Interfering RNA
DNA
Neoplasms

Keywords

  • 6-mercaptopurine
  • 6-thioguanine
  • childhood acute lymphoblastic leukemia
  • single nucleotide polymorphisms
  • thiopurine pharmacogenomics

ASJC Scopus subject areas

  • Pharmacology
  • Genetics
  • Molecular Medicine

Cite this

Matimba, A., Li, F., Livshits, A., Cartwright, C. S., Scully, S., Fridley, B. L., ... Lennard, L. (2014). Thiopurine pharmacogenomics: Association of SNPs with clinical response and functional validation of candidate genes. Pharmacogenomics, 15(4), 433-447. https://doi.org/10.2217/pgs.13.226

Thiopurine pharmacogenomics : Association of SNPs with clinical response and functional validation of candidate genes. / Matimba, Alice; Li, Fang; Livshits, Alina; Cartwright, Cher S.; Scully, Stephen; Fridley, Brooke L.; Jenkins, Gregory; Batzler, Anthony; Wang, Liewei M; Weinshilboum, Richard M; Lennard, Lynne.

In: Pharmacogenomics, Vol. 15, No. 4, 2014, p. 433-447.

Research output: Contribution to journalArticle

Matimba, A, Li, F, Livshits, A, Cartwright, CS, Scully, S, Fridley, BL, Jenkins, G, Batzler, A, Wang, LM, Weinshilboum, RM & Lennard, L 2014, 'Thiopurine pharmacogenomics: Association of SNPs with clinical response and functional validation of candidate genes', Pharmacogenomics, vol. 15, no. 4, pp. 433-447. https://doi.org/10.2217/pgs.13.226
Matimba, Alice ; Li, Fang ; Livshits, Alina ; Cartwright, Cher S. ; Scully, Stephen ; Fridley, Brooke L. ; Jenkins, Gregory ; Batzler, Anthony ; Wang, Liewei M ; Weinshilboum, Richard M ; Lennard, Lynne. / Thiopurine pharmacogenomics : Association of SNPs with clinical response and functional validation of candidate genes. In: Pharmacogenomics. 2014 ; Vol. 15, No. 4. pp. 433-447.
@article{ae67fae2041d45b7b705354f8b5fd4d2,
title = "Thiopurine pharmacogenomics: Association of SNPs with clinical response and functional validation of candidate genes",
abstract = "Aim: We investigated candidate genes associated with thiopurine metabolism and clinical response in childhood acute lymphoblastic leukemia. Materials & methods: We performed genome-wide SNP association studies of 6-thioguanine and 6-mercaptopurine cytotoxicity using lymphoblastoid cell lines. We then genotyped the top SNPs associated with lymphoblastoid cell line cytotoxicity, together with tagSNPs for genes in the 'thiopurine pathway' (686 total SNPs), in DNA from 589 Caucasian UK ALL97 patients. Functional validation studies were performed by siRNA knockdown in cancer cell lines. Results: SNPs in the thiopurine pathway genes ABCC4, ABCC5, IMPDH1, ITPA, SLC28A3 and XDH, and SNPs located within or near ATP6AP2, FRMD4B, GNG2, KCNMA1 and NME1, were associated with clinical response and measures of thiopurine metabolism. Functional validation showed shifts in cytotoxicity for these genes. Conclusion: The clinical response to thiopurines may be regulated by variation in known thiopurine pathway genes and additional novel genes outside of the thiopurine pathway.",
keywords = "6-mercaptopurine, 6-thioguanine, childhood acute lymphoblastic leukemia, single nucleotide polymorphisms, thiopurine pharmacogenomics",
author = "Alice Matimba and Fang Li and Alina Livshits and Cartwright, {Cher S.} and Stephen Scully and Fridley, {Brooke L.} and Gregory Jenkins and Anthony Batzler and Wang, {Liewei M} and Weinshilboum, {Richard M} and Lynne Lennard",
year = "2014",
doi = "10.2217/pgs.13.226",
language = "English (US)",
volume = "15",
pages = "433--447",
journal = "Pharmacogenomics",
issn = "1462-2416",
publisher = "Future Medicine Ltd.",
number = "4",

}

TY - JOUR

T1 - Thiopurine pharmacogenomics

T2 - Association of SNPs with clinical response and functional validation of candidate genes

AU - Matimba, Alice

AU - Li, Fang

AU - Livshits, Alina

AU - Cartwright, Cher S.

AU - Scully, Stephen

AU - Fridley, Brooke L.

AU - Jenkins, Gregory

AU - Batzler, Anthony

AU - Wang, Liewei M

AU - Weinshilboum, Richard M

AU - Lennard, Lynne

PY - 2014

Y1 - 2014

N2 - Aim: We investigated candidate genes associated with thiopurine metabolism and clinical response in childhood acute lymphoblastic leukemia. Materials & methods: We performed genome-wide SNP association studies of 6-thioguanine and 6-mercaptopurine cytotoxicity using lymphoblastoid cell lines. We then genotyped the top SNPs associated with lymphoblastoid cell line cytotoxicity, together with tagSNPs for genes in the 'thiopurine pathway' (686 total SNPs), in DNA from 589 Caucasian UK ALL97 patients. Functional validation studies were performed by siRNA knockdown in cancer cell lines. Results: SNPs in the thiopurine pathway genes ABCC4, ABCC5, IMPDH1, ITPA, SLC28A3 and XDH, and SNPs located within or near ATP6AP2, FRMD4B, GNG2, KCNMA1 and NME1, were associated with clinical response and measures of thiopurine metabolism. Functional validation showed shifts in cytotoxicity for these genes. Conclusion: The clinical response to thiopurines may be regulated by variation in known thiopurine pathway genes and additional novel genes outside of the thiopurine pathway.

AB - Aim: We investigated candidate genes associated with thiopurine metabolism and clinical response in childhood acute lymphoblastic leukemia. Materials & methods: We performed genome-wide SNP association studies of 6-thioguanine and 6-mercaptopurine cytotoxicity using lymphoblastoid cell lines. We then genotyped the top SNPs associated with lymphoblastoid cell line cytotoxicity, together with tagSNPs for genes in the 'thiopurine pathway' (686 total SNPs), in DNA from 589 Caucasian UK ALL97 patients. Functional validation studies were performed by siRNA knockdown in cancer cell lines. Results: SNPs in the thiopurine pathway genes ABCC4, ABCC5, IMPDH1, ITPA, SLC28A3 and XDH, and SNPs located within or near ATP6AP2, FRMD4B, GNG2, KCNMA1 and NME1, were associated with clinical response and measures of thiopurine metabolism. Functional validation showed shifts in cytotoxicity for these genes. Conclusion: The clinical response to thiopurines may be regulated by variation in known thiopurine pathway genes and additional novel genes outside of the thiopurine pathway.

KW - 6-mercaptopurine

KW - 6-thioguanine

KW - childhood acute lymphoblastic leukemia

KW - single nucleotide polymorphisms

KW - thiopurine pharmacogenomics

UR - http://www.scopus.com/inward/record.url?scp=84896364543&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84896364543&partnerID=8YFLogxK

U2 - 10.2217/pgs.13.226

DO - 10.2217/pgs.13.226

M3 - Article

C2 - 24624911

AN - SCOPUS:84896364543

VL - 15

SP - 433

EP - 447

JO - Pharmacogenomics

JF - Pharmacogenomics

SN - 1462-2416

IS - 4

ER -